Pyruvate kinase muscle 2 (PKM2) promotes CD4 T cell survival by regulating pyruvate oxidation during homeostasis and expansion
Glycolysis is an essential metabolic pathway for rapidly expanding T cells, but the role of pyruvate kinase muscle 1 (PKM1) and PKM2 in regulating this process is underappreciated. Here, using a pharmacological activator and targeted deletion of PKM2 in T cells, we delineated distinct functions of PKM1 and PKM2 in regulating CD4 T cell survival during homeostasis and expansion. Expanding PKM2-deficient CD4 T cells increased PKM1 expression with associated mitochondrial reactive oxygen species-mediated cell death. Examination of T cell compartments revealed that PKM2-deficient CD4 T cells were unaltered in the thymus but were significantly reduced in peripheral tissues as mice aged. The inability of PKM1 to protect CD4 T cells in the absence of PKM2 led to less severe T cell-mediated colitis as PKM2-deficient pathogenic cells were significantly reduced compared with control cells. This study shows that PKM2 is critical for CD4 T cell survival during expansion and homeostasis.
Authors
- Ian A. Bettencourt (ORCID: https://orcid.org/0000-0001-8154-7670)
- Erika M. Palmieri (ORCID: https://orcid.org/0000-0002-4237-5324)
- Scott Kenneth Durum (ORCID: https://orcid.org/0000-0003-1307-9582)
- Jeff Subleski
- Jessica Walls (ORCID: https://orcid.org/0000-0003-2901-3318)
- Steven H. Hsu (ORCID: https://orcid.org/0000-0001-5587-7844)
- Daniel W. McVicar (ORCID: https://orcid.org/0000-0002-1112-5111)
- Timothy R. Gower
Institutions
- Leidos (United States) (US)
- Trinity College Dublin (IE)
- Frederick National Laboratory for Cancer Research (US)
- Center for Cancer Research (US)
- Leidos Biomedical Research Inc. (United States)
- Michigan State University (US)
Publication Details
- Journal
- Science Advances
- Published
- 2026-01-30
- DOI
- https://doi.org/10.1126/sciadv.aec5092
- Citations
- 1
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 24.82